Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TARS | XENE | KNSA | ||
| Company | Tarsus Pharmaceuticals Inc | Xenon Pharmaceuticals Inc | Kiniksa Pharmaceuticals International Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 73.61 | 40.92 | 38.11 | ||
| High | 74.06 | 41.24 | 39.47 | ||
| Low | 70.99 | 39.97 | 38.04 | ||
| Latest | 71.14 | 39.98 | 39.41 | ||
| Change | -2.51 | -0.76 | +1.49 | ||
| % Change | -3.41% | -1.87% | +3.93% | ||
| Volume | 1,174,500 | 1,003,700 | 765,500 | ||
| 20-Day Average Volume | 708,960 | 999,880 | 576,255 | ||
| Previous Close | 73.65 | 40.74 | 37.92 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 78.92 | 42.89 | 41.41 | ||
| 20-Day Raw Stochastic | 1.15% | 0.16% | 32.30% | ||
| 20-Day Relative Strength | 35.02 | 42.18 | 45.49 | ||
| Weighted Alpha | +57.10 | +7.76 | +84.03 | ||
| Today's Opinion | 56% Buy | 40% Buy | 56% Buy | ||
| Previous Opinion | 56% Buy | 40% Buy | 40% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.45% since 01/09/26 | -5.15% since 01/09/26 | -7.64% since 01/09/26 | ||
| Low | 70.99 on 01/16/26 | 39.97 on 01/16/26 | 37.02 on 01/15/26 | ||
| High | 76.99 on 01/12/26 | 42.52 on 01/12/26 | 43.00 on 01/12/26 | ||
| 1-Month | |||||
| %Chg | -9.12% since 12/16/25 | -7.02% since 12/16/25 | -4.74% since 12/16/25 | ||
| Low | 70.99 on 01/16/26 | 39.97 on 01/16/26 | 37.02 on 01/15/26 | ||
| High | 84.07 on 12/24/25 | 46.36 on 12/31/25 | 44.42 on 12/22/25 | ||
| 3-Month | |||||
| %Chg | -5.11% since 10/16/25 | -5.19% since 10/16/25 | +1.26% since 10/16/25 | ||
| Low | 65.30 on 10/24/25 | 37.23 on 11/07/25 | 35.20 on 10/28/25 | ||
| High | 85.25 on 12/09/25 | 46.60 on 12/08/25 | 44.42 on 12/22/25 | ||
| 6-Month | |||||
| %Chg | +71.22% since 07/16/25 | +26.44% since 07/16/25 | +38.67% since 07/16/25 | ||
| Low | 38.51 on 08/01/25 | 30.00 on 08/01/25 | 26.27 on 07/25/25 | ||
| High | 85.25 on 12/09/25 | 46.60 on 12/08/25 | 44.42 on 12/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,019,822 | 3,089,455 | 2,987,120 | ||
| Shares Outstanding, K | 42,449 | 77,275 | 75,796 | ||
| Annual Sales | 182,950,000 | 0 | 423,240,000 | ||
| Annual Net Income | -115,550,000 | -234,330,000 | -43,190,000 | ||
| Last Quarter Sales | 118,700,000 | 0 | 180,860,000 | ||
| Last Quarter Net Income | -12,590,000 | -84,710,000 | 18,440,000 | ||
| 60-Month Beta | 0.59 | 0.97 | 0.04 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 11/04/25 | -1.15 on 11/03/25 | 0.23 on 10/28/25 | ||
| Latest Earnings Date | 02/24/26 | 02/26/26 | 02/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 84.27 | ||